Literature DB >> 1689823

Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys).

B Bordier1, L Tarrago-Litvak, M L Sallafranque-Andreola, D Robert, D Tharaud, M Fournier, P J Barr, S Litvak, L Sarih-Cottin.   

Abstract

Human immunodeficiency virus (HIV) reverse transcriptase (RT) uses host tRNA(Lys) partially annealed to the primer binding site (PBS) as primer for the initiation of cDNA synthesis. When assaying cDNA synthesis with a template-primer complex formed by an RNA fragment carrying the PBS site and bovine tRNA(Lys) we noticed that an excess of primer tRNA inhibited strongly the DNA polymerase activity of a recombinant HIV RT (p66-p51 heterodimeric form) produced in transformed yeast cells. The same inhibitory effect was observed with animal DNA polymerase alpha, while avian retrovirus RT was neither affected by tRNA(Lys) nor by its specific primer tRNA(Trp). Although the strongest inhibition was observed with tRNA(Lys), other tRNas like tRNA(Phe) and tRNA(Trp) inhibited also the HIV RT, whereas tRNAs specific for valine, proline and glycine had no effect on enzyme activity. Digestion of tRNA(Lys) with pancreatic RNase abolished the inhibition; on the other hand T1 RNase digestion had no effect on the inhibition suggesting a role of the anticodon region in this effect. The 12- and 14-mers corresponding to the anticodon regions of the three bovine tRNA(Lys) isoacceptors inhibited RT activity, indicating that at least an important part of the inhibitory effect could be ascribed to this tRNA region. A strong stimulation of DNA polymerase activity was observed when the effect of tRNA(Lys) was assayed on a recombinant HIV reverse transcriptase produced in a protease deficient yeast strain, which leads to the production of an active p66 enzyme. The same tRNAs that inhibited strongly the heterodimeric form stimulated the p66 form of HIV reverse transcriptase. The results suggest that although both enzymatic forms are able to interact with tRNA(Lys) the topography, as well as the functional implications of the interaction between the precursor and the mature form of HIV reverse transcriptase with the tRNA(Lys) primer, are different.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689823      PMCID: PMC333444          DOI: 10.1093/nar/18.3.429

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

2.  Exoribonuclease activity of purified reverse transcriptase preparations from retroviruses.

Authors:  Y Kikuchi; Y Ando; N Ichimura; A Noda
Journal:  J Biochem       Date:  1989-06       Impact factor: 3.387

3.  HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis.

Authors:  D M Lowe; A Aitken; C Bradley; G K Darby; B A Larder; K L Powell; D J Purifoy; M Tisdale; D K Stammers
Journal:  Biochemistry       Date:  1988-12-13       Impact factor: 3.162

4.  Human immunodeficiency virus reverse transcriptase-associated RNase H activity.

Authors:  M C Starnes; Y C Cheng
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Ribonuclease H activities associated with viral reverse transcriptases are endonucleases.

Authors:  M S Krug; S L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Human immunodeficiency virus reverse transcriptase expressed in transformed yeast cells. Biochemical properties and interactions with bovine tRNALys.

Authors:  M L Sallafranque-Andreola; D Robert; P J Barr; M Fournier; S Litvak; L Sarih-Cottin; L Tarrago-Litvak
Journal:  Eur J Biochem       Date:  1989-09-15

Review 8.  Retroviruses.

Authors:  H Varmus
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

9.  HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.

Authors:  C Barat; V Lullien; O Schatz; G Keith; M T Nugeyre; F Grüninger-Leitch; F Barré-Sinoussi; S F LeGrice; J L Darlix
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

10.  Identification and characterization of HIV-specific RNase H by monoclonal antibody.

Authors:  J Hansen; T Schulze; W Mellert; K Moelling
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  14 in total

1.  Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.

Authors:  A H Lund; M Duch; F S Pedersen
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase.

Authors:  S F Le Grice; M Panin; R C Kalayjian; N J Richter; G Keith; J L Darlix; S L Payne
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity.

Authors:  P Hafkemeyer; E Ferrari; J Brecher; U Hübscher
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Structure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1.

Authors:  T J Bardos; R F Schinazi; K H Ling; A R Heider
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication.

Authors:  A H Lund; M Duch; J Lovmand; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).

Authors:  J K Wakefield; S M Kang; C D Morrow
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1.

Authors:  Y Huang; J Mak; Q Cao; Z Li; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).

Authors:  J K Wakefield; A G Wolf; C D Morrow
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.

Authors:  J K Wakefield; H Rhim; C D Morrow
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.

Authors:  B Bordier; C Hélène; P J Barr; S Litvak; L Sarih-Cottin
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.